XBiotech Inc.

Healthcare · Biotechnology · United States

Last price 1.88 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 57.32M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

XBiotech Inc., a biopharmaceutical company, discovers, and develops, True Human monoclonal antibodies for treating various diseases. It develops a pipeline of product candidates targeting inflammatory and infectious diseases. The company is also developing interleukin-1 alpha therapies to various medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting, and general inflammation. The company was incorporated in 2005 and is headquarte...